1887

Access Microbiology open research platform logo

Volume 3, Issue 3

Application of a real-time cell analysis system in the process development and quantification of Rift Valley fever virus clone 13 Open Access

Abstract

Conventional cell-culture viral quantification methods, namely viral plaque and 50 % tissue culture infective dose assays, are time-consuming, subjective and are not suitable for routine testing. The viral plaque formation assay is the main method utilized for Rift Valley fever virus (RVFV) clone 13 quantification. The RVFV is a mosquito-borne RNA belonging to the family . The virus comprises a single serotype and causes the zoonotic Rift Valley fever disease. The real-time cell analysis (RTCA) system has been developed for the monitoring of cell growth, cell adhesion, cell viability and mortality using electronic impedance technology. In this study, Vero cell growth kinetics and RVFV clone 13 replication kinetics were investigated in a roller bottle and RTCA systems. In roller bottles, Vero cell growth was measured by cell counts through trypan blue staining, whilst impedance expressed as the cell index (CI) was used for Vero growth measurement in the RTCA system. Similar growth patterns were observed in both roller bottle and RTCA systems. Exponential growth phase was observed between 48 and 100 h, followed by a stationary phase from 100 to 120 h, before cell death was observed. Viral plaque assay quantification of RVFV clone 13 in the roller bottle system and the time required for the CI to decrease 50 % after virus infection (CIT50) in the RTCA system were comparable. The highest RVFV clone 13 titre was obtained at 120 h in both roller bottle and RTCA systems. An increase in time for cytopathic effect (CPE) formation was observed with a decrease in the concentration of the virus used to infect the RTCA plates. A positive correlation was observed between the viral concentration and the time for a CPE and was used to calculate CIT50. A similar correlation was observed between the viral concentration and the time for a CPE in the roller bottle system. This study shows that the RTCA system can be used as an alternative method for conducting cell culture kinetics and viral quantification.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): cell index , real-time cell analysis , Rift Valley fever , roller bottle system and viral plaque assay
Funding
This study was supported by the:
  • South African Agency for Science and Technology Advancement (Award 113982)
    • Principle Award Recipient: BoitumeloMoetlhoa
The Employers
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License.
Loading

Article metrics loading...

/content/journal/acmi/10.1099/acmi.0.000191
2020-12-17
2024-04-20
Loading full text...

Full text loading...

/deliver/fulltext/acmi/3/3/acmi000191.html?itemId=/content/journal/acmi/10.1099/acmi.0.000191&mimeType=html&fmt=ahah

References

  1. Daubney R, Hudson JR, Garnham PC. Enzootic hepatitis or Rift Valley fever. An undescribed virus disease of sheep cattle and man from East Africa. J Pathol Bacteriol 1931; 34:545–579 [View Article]
     [Google Scholar]
  2. Smithburn KC, Mahaffy AF, Haddow AJ, Kitchen SF, Smith JF. Rift Valley fever; accidental infections among laboratory workers. J Immunol 1949; 62:213–227 [PubMed]
     [Google Scholar]
  3. Linthicum KJ, Davies FG, Kairo DA, Bailey CL. Rift Valley fever virus (family Bunyaviridae, genus Phlebovirus) isolations from Diptera collected during an inter-epizootic period in Kenya. J Hyg 1985; 95:197–209 [View Article] [PubMed]
     [Google Scholar]
  4. Pepin M, Bouloy M, Bird BH, Kemp A, Paweska J. Rift Valley fever virus (Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention. Vet Res 2010; 41:61 [View Article] [PubMed]
     [Google Scholar]
  5. Daouam S, Fakri FZ, Ennaji MM, El Arkam A, Tadlaoui KO et al. Heat stability of the Rift Valley fever virus clone 13 live vaccines. Trials Vaccinol 2014; 3:61–64 [View Article]
     [Google Scholar]
  6. Elliott RM. Molecular biology of the Bunyaviridae . J Gen Virol 1990; 71:501–522 [View Article]
     [Google Scholar]
  7. Faburay B, LaBeaud AD, McVey DS, Wilson WC, Richt JA. Current status of Rift Valley fever vaccine development. Vaccines 2017; 5:29 [View Article] [PubMed]
     [Google Scholar]
  8. Filone CM, Heise M, Doms RW, Bertolotti-Ciarlet A. Development and characterization of a Rift Valley fever virus cell-cell fusion assay using alphavirus replicon vectors. Virology 2006; 356:155–164 [View Article] [PubMed]
     [Google Scholar]
  9. Von Teichman B, Engelbrecht A, Zulu G, Dungu B, Pardini A et al. Safety and efficacy of Rift Valley fever Smithburn and clone 13 vaccines in calves. Vaccine 2011; 29:5771–5777 [View Article] [PubMed]
     [Google Scholar]
  10. Charretier C, Saulnier A, Benair L, Armanet C, Bassard I et al. Robust real-time cell analysis method for determining viral infectious titers during development of a viral vaccine production process. J Virol Methods 2018; 252:57–64 [View Article] [PubMed]
     [Google Scholar]
  11. Dulbecco R. Production of plaques in monolayer tissue cultures by single particles of an animal virus. Proc Natl Acad Sci USA 1952; 38:747–752 [View Article] [PubMed]
     [Google Scholar]
  12. Kärber G. Beitrag zur kollektiven behandlung pharmakologischer reihenversuche [A contribution to the collective treatment of a pharmacological experimental series]. Arch Exp Pathol Pharmakol 1931; 162:480–483
     [Google Scholar]
  13. Rourou S, van der Ark A, Majoul S, Trabelsi K, van der Velden T et al. A novel animal-component-free medium for rabies virus production in Vero cells grown on Cytodex 1 microcarriers in a stirred bioreactor. Appl Microbiol Biotechnol 2009; 85:53–63 [View Article]
     [Google Scholar]
  14. Barron AL, Olshevsky C, Cohen MM. Characteristics of the BGM line of cells from African green monkey kidney. Arch Gesamte Virusforsch 1970; 32:389–392 [View Article] [PubMed]
     [Google Scholar]
  15. Teng Z, Kuang X, Wang J, Zhang X. Real-time cell analysis – a new method for dynamic, quantitative measurement of infectious viruses and antiserum neutralizing activity. J Virol Methods 2013; 193:364–370 [View Article] [PubMed]
     [Google Scholar]
  16. Liu J, Shi X, Schwartz R, Kemble G. Use of MDCK cells for production of live attenuated influenza vaccine. Vaccine 2009; 27:6460–6463 [View Article] [PubMed]
     [Google Scholar]
  17. Solly K, Wang X, Xu X, Strulovici B, Zheng W. Application of real-time cell electronic sensing (RT-CES) technology to cell-based assays. Assay Drug Dev Technol 2004; 2:363–372 [View Article] [PubMed]
     [Google Scholar]
  18. Fang Y, Ye P, Wang X, Xu X, Reisen W. Real-time monitoring of flavivirus induced cytopathogenesis using cell electric impedance technology. J Virol Methods 2011; 173:251–258 [View Article] [PubMed]
     [Google Scholar]
  19. Witzel F, Fritsche-Guenther R, Lehmann N, Sieber A, Blüthgen N. Analysis of impedance-based cellular growth assays. Bioinformatics 2015; 31:2705–2712 [View Article] [PubMed]
     [Google Scholar]
  20. Tennant JR. Evaluation of the trypan blue technique for determination of cell viability. Transplantation 1964; 2:685–694 [View Article] [PubMed]
     [Google Scholar]
  21. Spearman C. The proof and measurement of association between two things. Am J Psychol 1904; 15:72–101 [View Article]
     [Google Scholar]
  22. Rakers S, Imse F, Gebert M. Real-time cell analysis: sensitivity of different vertebrate cell cultures to copper sulfate measured by xCELLigence. Ecotoxicology 2014; 23:1582–1591 [View Article] [PubMed]
     [Google Scholar]
  23. Tian D, Zhang W, He J, Liu Y, Song Z et al. Correction: novel, real-time cell analysis for measuring viral cytopathogenesis and the efficacy of neutralizing antibodies to the 2009 influenza A (H1N1) virus. PLoS One 2012; 7:10.1371/annotation/9f718228-cb10-444b-882b-5dc795e9d1e7 [View Article]
     [Google Scholar]
  24. Burmakina G, Bliznetsov K, Malogolovkin A. Real-time analysis of the cytopathic effect of African swine fever virus. J Virol Methods 2018; 257:58–61 [View Article] [PubMed]
     [Google Scholar]
  25. Cerignoli F, Abassi YA, Lamarche BJ, Guenther G, Santa Ana D et al. In vitro immunotherapy potency assays using real-time cell analysis. PLoS One 2018; 13:e0193498 [View Article] [PubMed]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/acmi/10.1099/acmi.0.000191
Loading
Application of a real-time cell analysis system in the process development and quantification of Rift Valley fever virus clone 13
Access Microbiology 3, 000191 (2021); https://doi.org/10.1099/acmi.0.000191
/content/journal/acmi/10.1099/acmi.0.000191
/content/journal/acmi/10.1099/acmi.0.000191
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error